← Back to Clinical Trials
Recruiting NCT07447973

NCT07447973 Multimodal Deep Learning Model for Multi-task Diagnosis and Triage Suggestions of Ophthalmic Diseases

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07447973
Status Recruiting
Phase
Sponsor Guangdong Provincial People's Hospital
Condition Anterior Segment Diseases
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2025-07-28
Primary Completion 2027-11-20

Trial Parameters

Condition Anterior Segment Diseases
Sponsor Guangdong Provincial People's Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-07-28
Completion 2027-11-20
Interventions
Multimodal Vision-language Model Diagnosis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Accurate and comprehensive interpretation of anterior segment diseases from slit-lamp and smartphone photographs remains a clinical challenge due to the limited specificity and structure of existing Artificial Intelligence tools. The purpose of this international, multicenter clinical trial is to developed and validated an agent-based framework that integrates vision-language models and large language models to enhance the diagnostic workflow of anterior segment diseases.

Eligibility Criteria

Inclusion Criteria: 1. Informed consent obtained; 2. Participants should be sufficiently able to read, write, and understand Chinese or English; 3. For normal participants: individuals should have no concerns related to their eyes. 4. For participants with eye-related chief complaints: individuals should have specific concerns or issues related to their eyes. Exclusion Criteria: 1. Incomplete clinical data to support final diagnosis; 2. Patients who, in the opinion of the attending physician or clinical study staff, are too medically unstable to participate in the study safely.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology